Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisis

American Journal of Hematology

Volumn 90, Issue 5, 2015, Pages 381-385

  Manwani, Deepa ^a   Chen, Grace ^a   Carullo, Veronica ^a   Serban, Stelian ^b   Olowokure, Olugbenga ^b   Jang, Jungeun ^a   Huggins, Matthew ^a   Cohen, Hillel W ^a   Billett, Henny ^a   Atweh, George F ^b   Frenette, Paul S ^a,b   Shi, Patricia A ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HEADACHE; HUMAN; HYPERTENSION; LEUKOCYTE ACTIVATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RANDOMIZED CONTROLLED TRIAL; SICKLE CELL CRISIS; SINGLE DRUG DOSE; TREATMENT OUTCOME; TREATMENT RESPONSE; VEIN THROMBOSIS; ANEMIA, SICKLE CELL; BLOOD; CELL ADHESION; CLINICAL TRIAL; COMPLICATION; DRUG ADMINISTRATION; DRUG EFFECTS; METABOLISM; NEUTROPHIL; PAIN; PATHOLOGY; PATHOPHYSIOLOGY;

ACUTE CHEST SYNDROME; ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; CELL ADHESION; CHILD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MACROPHAGE-1 ANTIGEN; MALE; NEUTROPHIL ACTIVATION; NEUTROPHILS; PAIN;

EID: 84928285050     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.23956     Document Type: Article

References (27)

1. Turhan A, Jenab P, Bruhns P, et al. Intravenous immune globulin prevents venular vaso-occlusion in sickle cell mice by inhibiting leukocyte adhesion and the interactions between sickle erythrocytes and adherent leukocytes. Blood 2004;103:2397-2400.
2. Chang J, Shi PA, Chiang EY, et al. Intravenous immunoglobulins reverse acute vaso-occlusive crises in sickle cell mice through rapid inhibition of neutrophil adhesion. Blood 2008;111:915-923.
3. Hidalgo A, Chang J, Jang JE, et al. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med 2009;15:384-391.
4. Jang JE, Hidalgo A, Frenette PS. Intravenous immunoglobulins modulate neutrophil activation and vascular injury through FcgammaRIII and SHP-1. Circ Res 2012;110:1057-1066.
5. Simon SI, Chase S, Thackray H, et al. Inhibition of E-selectin inflammatory function by the glycomimetic GMI-1070. Blood: The American Society of Hematology; 2011;118:851.
6. Magnani JLKF, Patton JT, Larkin SK, et al. Pan-selectin antagonist GMI-1070 affects biomarkers of adhesion, activation and the coagulation cascade in sickle cell adults at steady state. Blood: the American Society of Hematology; 2012;120:87.
7. Telen MJWT, McCavit TL, DeCastro LM, et al. GMI 1070: Reduction in time to resolution of Vaso-occlusive crisis and decreased opioid use in a prospective, randomized, multi-center double blind, adaptive phase 2 study in sickle cell disease. Blood: the American Society of Hematology 2013;122:776.
8. Lin RY, Rodriguez-Baez G, Bhargave GA, et al. Intravenous gammaglobulin-associated renal impairment reported to the FDA: 2004-2009. Clin Nephrol 2011;76:365-372.
9. Gupta N, Ahmed I, Nissel-Horowitz S, et al. Intravenous gammglobulin-associated acute renal failure. Am J Hematol 2001;66:151-152.
10. Turhan A, Weiss LA, Mohandas N, et al. Primary role for adherent leukocytes in sickle cell vascular occlusion: A new paradigm. Proc Natl Acad Sci USA 2002;99:3047-3051.
11. Katayama Y, Hidalgo A, Chang J, et al. CD44 is a physiological E-selectin ligand on neutrophils. J Exp Med 2005;201:1183-1189.
12. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 2013;13:159-175.
13. Go RS, Call TG. Deep venous thrombosis of the arm after intravenous immunoglobulin infusion: Case report and literature review of intravenous immunoglobulin-related thrombotic complications. Mayo Clin Proc 2000;75:83-85.
14. Funk MB, Gross N, Gross S, et al. Thromboembolic events associated with immunoglobulin treatment. Vox Sang 2013;105:54-64.
15. Chopra V, An S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: A systematic review and meta-analysis. Lancet 2013;382:311-325.
16. Vichinsky EP, Neumayr LD, Earles AN, et al. Causes and outcomes of the acute chest syndrome in sickle cell disease. National acute chest syndrome study group. N Engl J Med 2000;342:1855-1865.
17. Sobota A, Graham DA, Neufeld EJ, et al. Thirty-day readmission rates following hospitalization for pediatric sickle cell crisis at freestanding children's hospitals: Risk factors and hospital variation. Pediatr Blood Cancer 2012;58:61-65.
18. Brousseau DC, Owens PL, Mosso AL, et al. Acute care utilization and rehospitalizations for sickle cell disease. JAMA 2010;303:1288-1294.
19. Casulli S, Topcu S, Fattoum L, et al. A differential concentration-dependent effect of IVIg on neutrophil functions: Relevance for anti-microbial and anti-inflammatory mechanisms. PloS One 2011;6:e26469.
20. Finnegan EM, Turhan A, Golan DE, et al. Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion. Am J Hematol 2007;82:266-275.
21. Almeida CB, Scheiermann C, Jang JE, et al. Hydroxyurea and a cGMP-amplifying agent have immediate benefits on acute vaso-occlusive events in sickle cell disease mice. Blood 2012;120:2879-2888.
22. Benkerrou M, Delarche C, Brahimi L, et al. Hydroxyurea corrects the dysregulated L-selectin expression and increased H(2)O(2) production of polymorphonuclear neutrophils from patients with sickle cell anemia. Blood 2002;99:2297-2303.
23. Gill V, Doig C, Knight D, et al. Targeting adhesion molecules as a potential mechanism of action for intravenous immunoglobulin. Circulation 2005;112:2031-2039.
24. Rigal D, Vermot-Desroches C, Heitz S, et al. Effects of intravenous immunoglobulins (IVIG) on peripheral blood B, NK, and T cell subpopulations in women with recurrent spontaneous abortions: Specific effects on LFA-1 and CD56 molecules. Clin Immunol Immunopathol 1994;71:309-314.
25. Hidalgo A, Peired AJ, Wild MK, et al. Complete identification of E-selectin ligands on neutrophils reveals distinct functions of PSGL-1, ESL-1, and CD44. Immunity 2007;26:477-489.
26. Wun T, Styles L, DeCastro L, et al. Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia. PloS One 2014;9:e101301.
27. Chang J, Patton JT, Sarkar A, et al. GMI-1070, a novel pan-selectin antagonist, reverses acute vascular occlusions in sickle cell mice. Blood 2010;116:1779-1786.